These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22292446)

  • 41. Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease.
    Pirlet C; Poirier P; Cieza T; Piché ME; Biertho L; Maes F; Ruzsa Z; Bertrand OF
    Am J Cardiovasc Drugs; 2021 May; 21(3):271-281. PubMed ID: 32812206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current Perspectives on Long-term Obesity Pharmacotherapy.
    Wharton S
    Can J Diabetes; 2016 Apr; 40(2):184-91. PubMed ID: 26507402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacotherapy of obesity - benefit, bias and hyperbole.
    Nair RP; Ren J
    Curr Med Chem; 2009; 16(15):1888-97. PubMed ID: 19442152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medications for weight loss.
    Mordes JP; Liu C; Xu S
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):91-7. PubMed ID: 25692921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome.
    Maksimov ML; Svistunov AA; Tarasov VV; Chubarev VN; Ávila-Rodriguez M; Barreto GE; Dralova OV; Aliev G
    Curr Pharm Des; 2016; 22(7):895-903. PubMed ID: 26648466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current and Future Medical Treatment of Obesity.
    Umashanker D; Igel LI; Kumar RB; Aronne LJ
    Gastrointest Endosc Clin N Am; 2017 Apr; 27(2):181-190. PubMed ID: 28292399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diabesity: are weight loss medications effective?
    Halpern A; Mancini MC
    Treat Endocrinol; 2005; 4(2):65-74. PubMed ID: 15783244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological Approaches in the Treatment and Maintenance of Weight Loss.
    Van Gaal L; Dirinck E
    Diabetes Care; 2016 Aug; 39 Suppl 2():S260-7. PubMed ID: 27440841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological management of obese child.
    Petkar R; Wright N
    Arch Dis Child Educ Pract Ed; 2013 Jun; 98(3):108-12. PubMed ID: 23475386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of lorcaserin in the management of obesity: a critical appraisal.
    Bai B; Wang Y
    Drug Des Devel Ther; 2010 Dec; 5():1-7. PubMed ID: 21267355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular Effects of the New Weight Loss Agents.
    Vorsanger MH; Subramanyam P; Weintraub HS; Lamm SH; Underberg JA; Gianos E; Goldberg IJ; Schwartzbard AZ
    J Am Coll Cardiol; 2016 Aug; 68(8):849-59. PubMed ID: 27539178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is cardiometabolic risk improved by weight-loss drugs?
    Astrup A
    Lancet; 2010 Aug; 376(9741):567-8. PubMed ID: 20673996
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiometabolic Effects of Anti-obesity Pharmacotherapy.
    Crawford AR; Alamuddin N; Amaro A
    Curr Atheroscler Rep; 2018 Mar; 20(4):18. PubMed ID: 29511882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multifaceted individualities in pharmacological treatments of obesity.
    Boban M
    Curr Clin Pharmacol; 2013 May; 8(2):89-96. PubMed ID: 22950960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Weight Loss Pharmacotherapy: Brief Summary of the Clinical Literature and Comments on Racial Differences.
    Egan BM; White K
    Ethn Dis; 2015 Nov; 25(4):511-4. PubMed ID: 26675365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug treatments for obesity.
    Couzigou P
    Lancet; 2007 Apr; 369(9568):1163-4; author reply 1164. PubMed ID: 17416249
    [No Abstract]   [Full Text] [Related]  

  • 57. Weight loss experiences and willingness to intervention with pharmacotherapy among obese and very obese Danish people.
    Jain P; Røstbjerg AS; Haase CL; Rhee NA
    Phys Sportsmed; 2016 Sep; 44(3):201-7. PubMed ID: 27254773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity.
    Igel LI; Sinha A; Saunders KH; Apovian CM; Vojta D; Aronne LJ
    Curr Atheroscler Rep; 2016 Apr; 18(4):16. PubMed ID: 26888066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why are anti-obesity drugs stigmatized?
    Halpern B; Halpern A
    Expert Opin Drug Saf; 2015 Feb; 14(2):185-9. PubMed ID: 25529104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacotherapy and weight-loss supplements for treatment of paediatric obesity.
    Rogovik AL; Chanoine JP; Goldman RD
    Drugs; 2010 Feb; 70(3):335-46. PubMed ID: 20166770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.